Brennan Carrithers
Psychiatry ResidentCards
About
Research
Publications
2026
Enhancing Psychiatry Education with Generative AI: A Pilot Study on AI-Assisted Object Relations Theory Training
Polet C, Anbarasan D, Carrithers B, Gershengoren L. Enhancing Psychiatry Education with Generative AI: A Pilot Study on AI-Assisted Object Relations Theory Training. Academic Psychiatry 2026, 1-4. PMID: 41735701, DOI: 10.1007/s40596-026-02302-2.Peer-Reviewed Original Research
2025
The Effect of Psychedelics on Individuals with a Personality Disorder: Results from Two Prospective Cohort Studies
Gordon A, Carrithers B, Pagni B, Kettner H, MRes A, Nayak S, Weiss B, Carhart-Harris R, Roberts D, Erritzoe D, Garcia-Romeu A, Jackson H, Lowe M, Zeifman R. The Effect of Psychedelics on Individuals with a Personality Disorder: Results from Two Prospective Cohort Studies. Psychedelic Medicine 2025 DOI: 10.1177/28314425251382930.Peer-Reviewed Original ResearchExploring serotonergic psychedelics as a treatment for personality disorders
Carrithers B, Roberts D, Weiss B, King J, Carhart-Harris R, Gordon A, Pagni B, Moreau M, Ross S, Zeifman R. Exploring serotonergic psychedelics as a treatment for personality disorders. Neuropharmacology 2025, 272: 110413. PMID: 40081794, DOI: 10.1016/j.neuropharm.2025.110413.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2024
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial
Pagni B, Zeifman R, Mennenga S, Carrithers B, Goldway N, Bhatt S, O'Donnell K, Ross S, Bogenschutz M. Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial. American Journal Of Psychiatry 2024, 182: 114-125. PMID: 39741446, DOI: 10.1176/appi.ajp.20230887.Peer-Reviewed Original ResearchConceptsPsilocybin-assisted therapyAlcohol use disorderUse disorderMedication sessionsNEO Personality InventoryPersonality trait expressionDisorders of addictionWeekly psychotherapy sessionsAlcohol consumptionPsilocybin groupTrait impulsivityPsychotherapy sessionsHigh-risk drinkingPersonality InventoryImpulsive individualsPersonality abnormalitiesPersonality dimensionsPlacebo-controlled clinical trialPersonality structureLow drinkingPersonality traitsTimeline FollowbackActive placeboPersonality changesDaily alcohol consumption
2020
Transdermal Asenapine in Schizophrenia: A Systematic Review
Carrithers B, El-Mallakh R. Transdermal Asenapine in Schizophrenia: A Systematic Review. Patient Preference And Adherence 2020, 14: 1541-1551. PMID: 32943849, PMCID: PMC7468370, DOI: 10.2147/ppa.s235104.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsTransdermal asenapinePlacebo-controlled studyPANSS scoresBipolar depressionBipolar illnessAcute psychosisAsenapineSchizophreniaTransdermal formulationsSystematic reviewSublingual formulationReceptor profilePsychosisPeak plasma concentrationWeek 6Total bioavailabilityElimination half-lifeFood and Drug AdministrationMultiple receptorsPlasma concentrationsPANSSPreferred Reporting ItemsAntipsychoticsClinical useDrug Administration